# Section 194: Etomidate

---

Etomidate
205
Etomidate
Mechanism of Action
Ultrashort-acting nonbarbiturate hypnotic used for rapid induction of anesthesia with minimal cardiovascular effects; modulates GABAA
receptors to induce general anesthesia. Does NOT have any analgesic properties
Uses
Conscious sedation, anesthesia for rapid-sequence intubation
Unlabeled uses: determine speech lateralization in patients prior to lobectomies to remove epileptogenic centers in the brain
Contraindications
Hypersensitivity
Precautions
Renal impairment, Elderly patients, Pregnancy category (C), unknown if excreted in breast milk
Protocol Uses
Rapid Sequence Airway – Adult (p33); Invasive Airway – Peds (p91)
Side Effects
Suppresses corticosteroid synthesis in the adrenal cortex by inhibiting 11-beta-hydroxylase, an enzyme important in adrenal steroid production.
CV: Arrhythmias, bradycardia, HTN, hypotension
GI: Nausea, vomiting on emergence from anesthesia
MS: Pain at injection site
Resp: Hiccups, laryngospasm, hypoventilation
Pharmacokinetics
Protein binding 76%, metabolized by hepatic and plasma esterases, excreted by kidneys, half life 1.25 hours
IV – Onset in 30-60 seconds, peak within 1 minute, duration approximately 3-5 minutes
Pregnancy Category – C
Interactions
No interactions listed on Lexi-Comp
EMT Considerations
Administer IV push over 30-60 seconds. Solution is highly irritating to small vessels
Assess vital signs, note muscle tone prior to and after injection, drug history, hepatic or renal failure
Assess for CNS changes – dizziness, somnolence, hallucinations, euphoria, LOC
Treatment of Overdose
Discontinue product; supportive care
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic
M Medical Control
EMR
